AUPH - Spark Newswire

3 minute read

Aurinia Pharmaceuticals Acquires Pipeline Assets Targeting Autoimmune And Kidney-related Diseases; Acquires AUR200For $750K Upfront Plus Potential Milestones, Acquires AUR300 From Riptide For $6M Plus Future Milestones

August 17, 6:08 AM

- Assets expand immunology portfolio to include B-cell therapy (BAFF/APRIL) and macrophage modulation - - IND-enabling studies are ongoing and will support the transition of these assets to clinical development in

AUPH

2 minute read

Movers

Analyzing Aurinia Pharmaceuticals’s Unusual Options Activity

By Benzinga Insights

August 11, 10:49 AM

Aurinia Pharmaceuticals (NASDAQ:AUPH) shares experienced unusual options activity on Wednesday. The stock price moved down to $14.96 following the option alert.

AUPH

6 minute read

84 Biggest Movers From Friday

By Lisa Levin

August 9, 5:20 AM

Gainers

ACOR

3 minute read

Mid-Afternoon Market Update: Dow Gains 140 Points; Spectrum Pharmaceuticals Shares Plummet

By Lisa Levin

August 6, 2:40 PM

Toward the end of trading Friday, the Dow traded up 0.40% to 35,204.21 while the NASDAQ fell 0.41% to 14,833.72. The S&P also rose, gaining 0.16% to 4,435.97.

ANY

3 minute read

Mid-Day Market Update: Gold Drops 2.5%; Sphere 3D Shares Spike Higher

By Lisa Levin

August 6, 12:11 PM

Midway through trading Friday, the Dow traded up 0.46% to 35,225.33 while the NASDAQ fell 0.70% to 14,791.01. The S&P also rose, gaining 0.07% to 4,432.28.

ANY

4 minute read

55 Stocks Moving In Friday’s Mid-Day Session

By Lisa Levin

August 6, 12:00 PM

Gainers

ADTN

6 minute read

The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO

By Shanthi Rexaline

August 6, 7:42 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 5)

ACAD

1 minute read

Aurinia Pharmaceuticals Q2 EPS $(0.37) Misses $(0.14) Estimate, Sales $6.62M Up From $29.00K YoY

By Benzinga Newsdesk

August 5, 5:27 PM

Aurinia Pharmaceuticals (NASDAQ:AUPH) reported quarterly losses of $(0.37) per share which missed the analyst consensus estimate of $(0.14) by 164.29 percent. This is a 42.31 percent decrease over losses of $(0.26) per

AUPH

7 minute read

88 Biggest Movers From Yesterday

By Lisa Levin

August 5, 5:18 AM

Gainers

ABSI

34 minute read

Earnings Scheduled For August 5, 2021

By Benzinga Insights

August 5, 4:08 AM

Companies Reporting Before The Bell • OneSpaWorld Holdings (NASDAQ:OSW) is projected to report quarterly loss at $0.20 per share on revenue of $6.42 million.

AAOI

Feed Symbols: AUPH